Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Mangold

Showing results (41-50 of 77) with videos related to

Pageof 8
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1994
Pharmacokinetics and metabolism of cyclosporin G in humansJ B Mangold, H F Schran, F L Tse
Mutation Research|February 1, 1989
Azidoalanine mutagenicity in Salmonella: effect of homologation and alpha-methyl substitutionJ B Mangold, M R Mischke, J M LaVelle
Clinical Pharmacokinetics|December 24, 2005
Clinical pharmacology of lumiracoxib: a selective cyclo-oxygenase-2 inhibitorChristiane M Rordorf, Les Choi, Paul Marshall, et al.
Padiatrie Und Padologie|January 1, 1992
[Organization of the psychotherapy-psychosomatic department and its integration into the University Pediatric Clinic]B Mangold, G Rathner, E Rosenkranz, et al.
Arzneimittel-Forschung|November 1, 1989
[Human pharmacologic studies on transdermal administration of mepindolol. Pharmacodynamic and orienting pharmacokinetics]R K Liedtke, L S Chen, B Mangold, et al.
Bioanalysis|March 14, 2014
An industry perspective on tiered approach to the investigation of metabolites in drug developmentSu-Er W Huskey, Wenkui Li, James B Mangold, et al.
Mutation Research|July 1, 1994
Effects of deuterium labeling on azido amino acid mutagenicity in Salmonella typhimuriumJ B Mangold, Y Du, M R Mischke, et al.
Biopharmaceutics & Drug Disposition|April 1, 1990
Pharmacokinetics and absolute bioavailability of ibuprofen after oral administration of ibuprofen lysine in manW Martin, G Koselowske, H Töberich, et al.
Clinical Pharmacology and Therapeutics|May 1, 1999
Pharmacodynamic effects of dual neutral endopeptidase-angiotensin-converting enzyme inhibition versus angiotensin-converting enzyme inhibition in humansC Massien, M Azizi, T T Guyene, et al.
Carcinogenesis|September 1, 1990
Self-catalyzed irreversible inactivation of rat hepatic aryl sulfotransferase IV by N-hydroxy-2-acetylaminofluoreneB L Mangold, J Erickson, C Lohr, et al.
Pageof 8

Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1994
Pharmacokinetics and metabolism of cyclosporin G in humansJ B Mangold, H F Schran, F L Tse
Mutation Research|February 1, 1989
Azidoalanine mutagenicity in Salmonella: effect of homologation and alpha-methyl substitutionJ B Mangold, M R Mischke, J M LaVelle
Clinical Pharmacokinetics|December 24, 2005
Clinical pharmacology of lumiracoxib: a selective cyclo-oxygenase-2 inhibitorChristiane M Rordorf, Les Choi, Paul Marshall, et al.
Padiatrie Und Padologie|January 1, 1992
[Organization of the psychotherapy-psychosomatic department and its integration into the University Pediatric Clinic]B Mangold, G Rathner, E Rosenkranz, et al.
Arzneimittel-Forschung|November 1, 1989
[Human pharmacologic studies on transdermal administration of mepindolol. Pharmacodynamic and orienting pharmacokinetics]R K Liedtke, L S Chen, B Mangold, et al.
Bioanalysis|March 14, 2014
An industry perspective on tiered approach to the investigation of metabolites in drug developmentSu-Er W Huskey, Wenkui Li, James B Mangold, et al.
Mutation Research|July 1, 1994
Effects of deuterium labeling on azido amino acid mutagenicity in Salmonella typhimuriumJ B Mangold, Y Du, M R Mischke, et al.
Biopharmaceutics & Drug Disposition|April 1, 1990
Pharmacokinetics and absolute bioavailability of ibuprofen after oral administration of ibuprofen lysine in manW Martin, G Koselowske, H Töberich, et al.
Clinical Pharmacology and Therapeutics|May 1, 1999
Pharmacodynamic effects of dual neutral endopeptidase-angiotensin-converting enzyme inhibition versus angiotensin-converting enzyme inhibition in humansC Massien, M Azizi, T T Guyene, et al.
Carcinogenesis|September 1, 1990
Self-catalyzed irreversible inactivation of rat hepatic aryl sulfotransferase IV by N-hydroxy-2-acetylaminofluoreneB L Mangold, J Erickson, C Lohr, et al.
Pageof 8